Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Lynn (Blackrock (Co. Dublin), Ireland), J. Morrow (Blackrock (Co. Dublin), Ireland), A. Fabre (Blackrock (Co. Dublin), Ireland), J. Dodd (Blackrock (Co. Dublin), Ireland), D. Murphy (Blackrock (Co. Dublin), Ireland), M. Keane (Blackrock (Co. Dublin), Ireland), C. Mccarthy (Blackrock (Co. Dublin), Ireland). Prevalence of lymphangioleiomyomatosis in an Irish population and biomarker utility. 4239

Member's Comments

No comment yet.

Related content which might interest you: SP-D as a biomarker for COPD in the Lebanese population Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Bronchiectasis severity assessment tools to predict clinical outcomes in the Indian Bronchiectasis Registry Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Prevalence, severity and impact of asthma in the French general population Source: Eur Respir J 2005; 26: Suppl. 49, 265s Year: 2005 Prevalence of asymptomatic bronchiectasis and associations among the health screening population in South Korea Source: ERJ Open Res, 7 (3) 00188-2021; 10.1183/23120541.00188-2021 Year: 2021 Validation of an etiological diagnostic model in adults with a diagnosis of bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Patterns of airway disease and the clinical diagnosis of asthma in the Busselton population Source: Eur Respir J 2011; 38: 1053-1059 Year: 2011 Prognostic factors affecting survival of idiopathic pulmonary fibrosis in Korean population Source: Eur Respir J 2007; 30: Suppl. 51, 578s Year: 2007 Validation of a Japanese version of the COPD diagnostic questionnaire in the general Asian population: The Hisayama study Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021 Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study Source: ERJ Open Res, 7 (1) 00754-2020; 10.1183/23120541.00754-2020 Year: 2021 Clinical characteristics of lymphangioleiomyomatosis and application of a novel automated cyst burden score Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Role of symptom assessment and spirometry in early COPD detection in Indian population Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009 Evaluation of known risk factors for asthma in an Argentine asthmatic paediatric population in relationship to severity Source: Eur Respir J 2001; 18: Suppl. 33, 453s Year: 2001 Prevalence and control of current asthma in Portuguese paediatric population Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma Year: 2011 Obesity and its implications for COVID-19 evolution in Tunisian population Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021 Incidence and remission of asthma in Australian children: findings from a population cohort Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 Prevalence of COPD in a general population Source: Eur Respir J 2005; 26: Suppl. 49, 593s Year: 2005 Atopy can determine sarcoid outcome – an Irish cohort of newly diagnosed sarcoidosis Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007